Your browser doesn't support javascript.
loading
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer.
Hwang, Justin H; Seo, Ji-Heui; Beshiri, Michael L; Wankowicz, Stephanie; Liu, David; Cheung, Alexander; Li, Ji; Qiu, Xintao; Hong, Andrew L; Botta, Ginevra; Golumb, Lior; Richter, Camden; So, Jonathan; Sandoval, Gabriel J; Giacomelli, Andrew O; Ly, Seav Huong; Han, Celine; Dai, Chao; Pakula, Hubert; Sheahan, Anjali; Piccioni, Federica; Gjoerup, Ole; Loda, Massimo; Sowalsky, Adam G; Ellis, Leigh; Long, Henry; Root, David E; Kelly, Kathleen; Van Allen, Eliezer M; Freedman, Matthew L; Choudhury, Atish D; Hahn, William C.
Afiliación
  • Hwang JH; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Seo JH; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Beshiri ML; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Wankowicz S; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Liu D; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cheung A; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li J; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Qiu X; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hong AL; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Botta G; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Golumb L; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Richter C; Dana-Farber Cancer Institute, Boston, MA, USA.
  • So J; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Sandoval GJ; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Giacomelli AO; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Ly SH; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Han C; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Dai C; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Pakula H; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sheahan A; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Piccioni F; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Gjoerup O; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Loda M; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Sowalsky AG; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Ellis L; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.
  • Long H; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Root DE; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Kelly K; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Van Allen EM; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Freedman ML; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Choudhury AD; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Hahn WC; Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Brigham and Women's Hospital, Boston, MA, USA. Electronic address: william_hahn@dfci.harvard.edu.
Cell Rep ; 29(8): 2355-2370.e6, 2019 11 19.
Article en En | MEDLINE | ID: mdl-31747605
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína de Unión al Elemento de Respuesta al AMP Cíclico / Antagonistas de Receptores Androgénicos Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Cell Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína de Unión al Elemento de Respuesta al AMP Cíclico / Antagonistas de Receptores Androgénicos Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Cell Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos